Isotretinoin: an expert UK review of suspected psychiatric and sexual side effects- Review from 2021 with results in 2023
The review of the safety of isotretinoin/Roaccutane has concluded.
A great deal of thought and anguish for those bereaved or harmed they believed was after or during the use Roaccutane/ isotretinoin, prescribed for acne, before they sent in written evidence or / and spoke in meetings with some of the Istotretinoin Expert Working Group (IEWG).
The three meetings videos of the evidence from patients, bereaved family members and doctors are on the .Gov site
The final discussion on findings following evidence sessions is here:
https://www.youtube.com/watch?v=jOX6hASHdTM
it may be of interest that the manufacturer Roche have ceased being responsible for the sale of isotretinoin/ Accutane in the USA - the amount of litigation linking the adverse effects to Inflammatory Bowel Disease in the US was not said to be the reason. However I spoke to a generic provider of the drug in the UK and was told Roche provides them with the drugs.
Before this the evidence sessions on Zoom occurred and we had all sent in written evidence too.
Contributions from patients and the public
A call for information was held for 14 weeks (10 November 2020 to 16 February 2021). A total of 710 complete responses were received. These included 659 responses that provided views. We have assessed each one and shared the responses with the IEWG.
Patients and other stakeholders presented information about their experience of isotretinoin and what aspect of treatment has had the greatest impact as well as how the risks associated with isotretinoin should be managed.
Three sessions were held to allow the IEWG to hear from everyone who registered and wished to present.
See recordings of the 3 IEWG sessions with stakeholders. These videos have been edited to only show the views of those who consented to being recorded. The videos contain content that some people may find upsetting:
- IEWG Meeting 16 July 2021 https://www.youtube.com/watch?v=xTlvBr4QstI
- IEWG Meeting 21 July Meeting (morning session)
- https://www.youtube.com/watch?v=OxUOo5DK_zg
- IEWG Meeting 21 July 2021 Afternoon Session
- https://www.youtube.com/watch?v=KA2xlhmYr_o
It is worth hearing the above sessions for real patient experiences. There are generic versions of isotretinoin and it should only be prescribed by consultant dermatologists, not by GPs or obtained from the Internet.
isotretinoin is marketed as Absorica, Absorica LD, Claravis, Amnesteem, Myorisan, and Zenatane, and is sometimes referred to by its former brand name, Accutane
Rizuderm, Reticutan in the UK
No comments:
Post a Comment